摘要
目的探讨豁痰清窍解郁汤联合抗抑郁药治疗脑卒中后抑郁(PSD)的效果。方法选取2019年12月至2020年12月青岛大学附属青岛市海慈医院收治的PSD患者80例,采用随机数字表法将其分为观察组和对照组,每组40例。对照组在常规治疗的基础上接受盐酸氟西汀分散片,观察组在对照组的基础上加用豁痰清窍解郁汤治疗,两组连续治疗2个月。比较两组一般资料、临床疗效和治疗前后中医证候评分、美国国立卫生研究院卒中量表(NIHSS)评分、简易智力状态检查量表(MMSE)评分、IL-1、IL-2、5-羟色胺(5-HT)及不良反应发生率。结果观察组临床疗效优于对照组(P<0.05)。两组治疗后情志抑郁、咽喉异物感、胸闷、胁肋刺痛、舌质暗紫或瘀斑、脉细涩评分及中医证候总分分别低于本组治疗前,且观察组治疗后情志抑郁、咽喉异物感、舌质暗紫或瘀斑、脉细涩评分及中医证候总分低于对照组(P<0.05)。两组治疗后NIHSS评分分别低于本组治疗前、MMSE评分分别高于本组治疗前,且观察组治疗后NIHSS评分低于对照组、MMSE评分高于对照组(P<0.05)。两组治疗后IL-1、IL-2分别低于本组治疗前,5-HT分别高于本组治疗前,且观察组治疗后IL-1、IL-2低于对照组,5-HT高于对照组(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论豁痰清窍解郁汤联合抗抑郁药能提高PSD患者临床疗效,改善患者中医证候、神经功能及认知功能,且具有一定安全性,值得在PSD患者的临床治疗中推广。
Objective To explore the effect of Huotan Qingqiao Jieyu decoction combined with antidepressant in the treatment of post-stroke depression(PSD).Methods A total of 80 patients with PSD admitted to Qingdao Haici Hospital Affiliated to Qingdao University from December 2019 to December 2020 were selected and divided into observation group and control group by random number table method,with 40 cases in each group.The control group was given fluoxetine hydrochloride dispersible tablets on the basis of conventional treatment.The observation group was treated with Huotan Qingqiao Jieyu decoction on the basis of the control group.Both groups were continuously treated for 2 months.The general data,clinical efficacy and TCM syndrome score,National Institutes of Health Stroke Scale(NIHSS)score,Mini-Mental State Examination(MMSE)score,IL-1,IL-2 and 5-hydroxytryptamine(5-HT)before and after treatment and the incidence of adverse reactions were compared between the two groups.Results The clinical efficacy of observation group was better than that of control group(P<0.05).After treatment,the score of emotional depression,score of foreign body sensation in the throat,score of chest distress,score of tingling in the flank,score of dark purple or ecchymosis of tongue,score of thin and astringent pulse,and total score of TCM syndrome in the two groups were lower than those before treatment respectively,and the score of emotional depression,score of foreign body sensation in the throat,score of dark purple or ecchymosis of tongue,score of thin and astringent pulse,total score of TCM syndrome in the observation group were lower than those in the control group(P<0.05).After treatment,the NIHSS score of the two groups after treatment was lower than that before treatment,and the MMSE score was higher than that before treatment,respectively,NIHSS score in observation group was lower than that of control group,MMSE score was higher than that of control group(P<0.05).After treatment,IL-1 and IL-2 in the two groups were lower than those before treatment,and 5-HT was higher than that before treatment,respectively,and IL-1 and IL-2 in observation group were lower than those in control group,and 5-HT was higher than that in control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P<0.05).Conclusion Huotan Qingqiao Jieyu decoction combined with antidepressant can improve the clinical efficacy of PSD patients,improve the TCM syndrome,neurological function and cognitive function of patients,and has a certain safety,which is worthy of promotion in the clinical treatment of PSD patients.
作者
李宁
吕以静
LI Ning;LYU Yijing(Department of Neurology,Qingdao Haici Hospital Affiliated to Qingdao University,Qingdao 266000,China)
出处
《实用心脑肺血管病杂志》
2023年第9期99-102,106,共5页
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
基金
山东省自然科学基金面上项目(ZR202103030420)。
关键词
抑郁
卒中
豁痰清窍解郁汤
治疗结果
Depression
Stroke
Huotan Qingqiao Jieyu decoction
Treatment outcome